Overview
Regional variants of Guillain-Barré syndrome (GBS) are a group of acute immune-mediated neuropathies that affect specific, limited regions of the peripheral nervous system rather than causing the widespread ascending paralysis seen in classic GBS. These variants are considered incomplete or localized forms of the broader Guillain-Barré spectrum. They typically develop days to weeks after an infectious illness, most commonly a respiratory or gastrointestinal infection, and are thought to result from molecular mimicry in which antibodies generated against infectious agents cross-react with components of peripheral nerves. Regional variants include conditions such as pharyngeal-cervical-brachial (PCB) weakness, facial diplegia with paresthesias, and other localized presentations that do not meet criteria for the more well-known Miller Fisher syndrome or classic acute inflammatory demyelinating polyneuropathy (AIDP). In pharyngeal-cervical-brachial variant, patients experience weakness predominantly in the oropharyngeal, neck, and upper limb muscles, which can lead to difficulty swallowing, neck weakness, and arm weakness while the legs are relatively spared. Facial diplegia with paresthesias presents with bilateral facial weakness and sensory symptoms in the limbs. Anti-ganglioside antibodies, such as anti-GT1a or anti-GQ1b, may be detected in some patients, supporting the autoimmune etiology. Diagnosis is based on clinical presentation, nerve conduction studies, cerebrospinal fluid analysis (which may show albuminocytologic dissociation), and serological testing for anti-ganglioside antibodies. Treatment follows the same principles as classic GBS and includes intravenous immunoglobulin (IVIg) or plasma exchange (plasmapheresis), along with supportive care including monitoring for respiratory compromise. Most patients have a favorable prognosis with gradual recovery over weeks to months, though some may experience residual deficits. Early recognition is important to distinguish these variants from other neurological emergencies such as brainstem stroke or myasthenia gravis.
Also known as:
Sporadic
Usually appears on its own, not inherited from a parent
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Regional variant of Guillain-Barré syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Regional variant of Guillain-Barré syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Regional variant of Guillain-Barré syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Regional variant of Guillain-Barré syndrome.
Community
No community posts yet. Be the first to share your experience with Regional variant of Guillain-Barré syndrome.
Start the conversation →Latest news about Regional variant of Guillain-Barré syndrome
No recent news articles for Regional variant of Guillain-Barré syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Regional variant of Guillain-Barré syndrome
What is Regional variant of Guillain-Barré syndrome?
Regional variants of Guillain-Barré syndrome (GBS) are a group of acute immune-mediated neuropathies that affect specific, limited regions of the peripheral nervous system rather than causing the widespread ascending paralysis seen in classic GBS. These variants are considered incomplete or localized forms of the broader Guillain-Barré spectrum. They typically develop days to weeks after an infectious illness, most commonly a respiratory or gastrointestinal infection, and are thought to result from molecular mimicry in which antibodies generated against infectious agents cross-react with compo
How is Regional variant of Guillain-Barré syndrome inherited?
Regional variant of Guillain-Barré syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.